Association of elevated triglycerides and acute myocardial infarction in young Hispanics

Gilbert Essilfie1, David M Shavelle1, Han Tun1

  • 1Division of Cardiovascular Medicine, University of Southern California, Keck School of Medicine, Los Angeles, CA, 90033.

Insights

Young Hispanic individuals experiencing acute myocardial infarction (AMI) show higher triglyceride levels compared to other groups. These elevated levels may stem from lifestyle shifts associated with immigration to the United States.

Area of Science:

  • Cardiology
  • Ethnic Health Disparities
  • Metabolic Syndrome

Background:

  • Acute myocardial infarction (AMI) in younger patients (<45 years) is linked to smoking, obesity, and hyperlipidemia.
  • Hispanics are the largest growing ethnic minority in the U.S., but AMI characteristics in young Hispanics remain understudied.

Purpose of the Study:

  • To describe the unique features of AMI in young Hispanic patients.
  • To compare young Hispanic AMI patients with young non-Hispanic and older Hispanic patients.

Main Methods:

  • Retrospective study of patients undergoing percutaneous coronary intervention for AMI.
  • Comparison of young Hispanics (age <45) with older patients (age ≥45) and young non-Hispanics.
  • Multivariable logistic regression to identify factors associated with in-hospital mortality.

Main Results:

  • Young Hispanics exhibited significantly higher triglyceride levels than young non-Hispanics and older patients (p<0.0004).
  • Body mass index was independently associated with triglyceride levels (p<0.0001).
  • Hispanic ethnicity and age <45 were not independently associated with in-hospital mortality.

Conclusions:

  • Young Hispanic patients with AMI present with elevated triglyceride levels compared to other demographic groups.
  • Lifestyle changes in young immigrant populations transitioning to the U.S. may contribute to these elevated triglyceride levels.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
567
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
813